Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1993-4-22
|
pubmed:abstractText |
The histamine H2-receptor antagonistic activity and antisecretory effects of KU-1257 (N-ethyl-N'-[3-[3-(piperidinomethyl) phenoxy]propyl]urea, CAS 120958-90-9) were studied. The Ki values of KU-1257, roxatidine acetate, famotidine and cimetidine for the inhibition of [3H]-tiotidine binding to guinea-pig cerebral cortex were 0.040, 0.13, 0.016 and 0.40 mumol/l, respectively. The KB values of KU-1257, roxatidine acetate, famotidine and cimetidine for the antagonism against histamine-induced positive chronotropic response of isolated guinea-pig right atrium were 0.041, 0.14, 0.031 and 0.51 mumol/l, respectively. In pylorus-ligated rats, KU-1257, roxatidine acetate and famotidine inhibited gastric acid secretion with respective intraduodenal ID50 values of 12.3, 18.5 and 0.45 mg/kg. In dogs with Heidenhain pouch, the ID50 values of KU-1257 for the inhibition of acid output stimulated by histamine, tetragastrin and meat meal were 0.08, 0.39 and 0.15 mg/kg p.o., respectively. KU-1257 was 2-3 times more potent than roxatidine acetate regardless of secretagogues and twice less than famotidine in meat meal stimulation. These results indicate that KU-1257 is a potent and competitive histamine H2-receptor antagonist.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cimetidine,
http://linkedlifedata.com/resource/pubmed/chemical/Famotidine,
http://linkedlifedata.com/resource/pubmed/chemical/Histamine H2 Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Phenylurea Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Piperidines,
http://linkedlifedata.com/resource/pubmed/chemical/Tetragastrin,
http://linkedlifedata.com/resource/pubmed/chemical/roxatidine acetate,
http://linkedlifedata.com/resource/pubmed/chemical/tiotidine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0004-4172
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
129-33
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8096132-Animals,
pubmed-meshheading:8096132-Cerebral Cortex,
pubmed-meshheading:8096132-Cimetidine,
pubmed-meshheading:8096132-Dogs,
pubmed-meshheading:8096132-Famotidine,
pubmed-meshheading:8096132-Food,
pubmed-meshheading:8096132-Gastric Acid,
pubmed-meshheading:8096132-Guinea Pigs,
pubmed-meshheading:8096132-Heart Atria,
pubmed-meshheading:8096132-Heart Rate,
pubmed-meshheading:8096132-Histamine H2 Antagonists,
pubmed-meshheading:8096132-Kinetics,
pubmed-meshheading:8096132-Male,
pubmed-meshheading:8096132-Phenylurea Compounds,
pubmed-meshheading:8096132-Piperidines,
pubmed-meshheading:8096132-Pylorus,
pubmed-meshheading:8096132-Rats,
pubmed-meshheading:8096132-Rats, Wistar,
pubmed-meshheading:8096132-Tetragastrin
|
pubmed:year |
1993
|
pubmed:articleTitle |
Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
|
pubmed:affiliation |
Central Research Laboratories, Kyorin Pharmaceutical Co., Ltd., Tochigi, Japan.
|
pubmed:publicationType |
Journal Article,
In Vitro
|